TempTraq: Digital Health Technology Revolutionizing Clinical Oncology Trials
Ensuring consistency and accuracy in data collection through digital health technology (DHT) is paramount in the rapidly evolving landscape...
Moe Alsumidaie
Eye-Opening FDA Strategies to Ensure Global Drug Safety
The FDA Town Hall at the 2024 DIA Europe Conference provided an insightful overview of the FDA’s strategic initiatives...
Middle East Clinical Trial Regulatory Update: Pioneering Frameworks
The Middle East Town Hall at DIA Europe 2024 showcased significant Middle East clinical trial regulatory advancements across the...
AI’s Astonishing Impact on Drug Development and Ethics
The 2024 DIA Europe conference hosted a forward-thinking session titled “AI in Medicines Regulation: Beyond our Imagination.” The session...
Powerful Innovations in Medical Device Software at DIA Europe 2024
The 2024 DIA Europe Conference brought together industry experts to explore the rapidly evolving medical device software and connected...
In-Silico Breakthrough: EMA’s Shift from Animal Testing
The DIA Europe 2024 conference brought together leading experts to discuss groundbreaking innovations and regulatory strategies in clinical trials....
BridGene Biosciences and How It Aims to Target Hard to Drug Proteins
In this interview, Dr. Ping Cao, co-founder and CEO of BridGene Biosciences, discusses targeting “hard to drug” proteins that...
EMA Needs To Release DHT Guidance Now
As digital health technologies (DHTs) increasingly permeate the landscape of clinical trials, the European Medicines Agency (EMA) faces mounting...
How CNS Trials Transform with Innovative Digital Tech
In this interview on integrating innovative digital technologies in central nervous system (CNS) trials, I engaged with Matthew Stork,...
How To Engage The FDA when Building Clinical Trial DHTs
Integrating Digital Health Technologies (DHTs) in drug development is revolutionizing clinical trials, especially with the rise of decentralized clinical...